American National Insurance’s BioMarin Pharmaceuticals BMRN Stock Holding History

American National Insurance’s Portfolio BMRN Stock Details BMRN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q1	$264K	Sell	3,425 -865	-20%	-$72.4K	0.07%	238
2021 Q4	$379K	Sell	4,290 -23,700	-85%	-$1.96M	0.08%	227
2021 Q3	$2.16M	Sell	27,990 -30	-0.1%	-$2.37K	0.08%	208
2021 Q2	$2.34M	Sell	28,020 -50	-0.2%	-$3.96K	0.09%	207
2021 Q1	$2.12M	Sell	28,070 -25	-0.1%	-$2.04K	0.09%	207
2020 Q4	$2.46M	Hold	28,095	–	–	0.11%	189
2020 Q3	$2.14M	Hold	28,095	–	–	0.1%	184
2020 Q2	$3.46M	Hold	28,095	–	–	0.18%	143
2020 Q1	$2.37M	Hold	28,095	–	–	0.15%	154
2019 Q4	$2.38M	Hold	28,095	–	–	0.12%	173
2019 Q3	$1.89M	Hold	28,095	–	–	0.1%	185
2019 Q2	$2.41M	Hold	28,095	–	–	0.13%	174
2019 Q1	$2.5M	Hold	28,095	–	–	0.13%	173
2018 Q4	$2.39M	Hold	28,095	–	–	0.14%	165
2018 Q3	$2.72M	Hold	28,095	–	–	0.13%	169
2018 Q2	$2.65M	Hold	28,095	–	–	0.13%	178
2018 Q1	$2.28M	Hold	28,095	–	–	0.12%	186
2017 Q4	$2.5M	Hold	28,095	–	–	0.13%	183
2017 Q3	$2.62M	Hold	28,095	–	–	0.14%	179
2017 Q2	$2.55M	Hold	28,095	–	–	0.14%	175
2017 Q1	$2.47M	Hold	28,095	–	–	0.14%	179
2016 Q4	$2.33M	Hold	28,095	–	–	0.14%	178
2016 Q3	$2.6M	Hold	28,095	–	–	0.15%	178
2016 Q2	$2.19M	Hold	28,095	–	–	0.13%	196
2016 Q1	$2.32M	Sell	28,095 -105	-0.4%	-$8.54K	0.14%	188
2015 Q4	$2.95M	Buy	+28,200	New	+$2.94M	0.18%	161

Other funds holding BMRN

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

BBA

Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return

American National Insurance's BMRN Position: Q1 2022 in Review

American National Insurance reduced its BioMarin Pharmaceuticals (BMRN) stake by 20% in Q1 2022, selling an estimated $72.4K and leaving 3,425 shares worth $264K. The position accounts for 0.07% of the portfolio, ranked #238.

American National Insurance first reported a position in BMRN in Q4 2015 and has held it in 26 quarters since. The position peaked at $3.46M in Q2 2020. 560 funds tracked by Wall St. Rank hold BMRN as of Q1 2022.

American National Insurance held 3,425 shares of BioMarin Pharmaceuticals worth $264K as of Q1 2022.
American National Insurance sold 865 BioMarin Pharmaceuticals shares in Q1 2022, an estimated $72.4K.
BioMarin Pharmaceuticals made up 0.07% of American National Insurance's portfolio in Q1 2022, its #238 holding.
American National Insurance first reported a position in BioMarin Pharmaceuticals in Q4 2015 and has held it in 26 quarters since.
American National Insurance's BioMarin Pharmaceuticals position peaked at $3.46M in Q2 2020.
560 funds tracked by Wall St. Rank held BioMarin Pharmaceuticals as of Q1 2022.

Based on American National Insurance's 13F filing for Q1 2022, filed 13 May 2022.